# A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery

> **NCT00467181** · PHASE2 · COMPLETED · sponsor: **Summa Health System** · enrollment: 30 (estimated)

## Conditions studied

- Cardiac Surgery With Cardiopulmonary Bypass

## Interventions

- **DRUG:** Fenoldopam

## Key facts

- **NCT ID:** NCT00467181
- **Lead sponsor:** Summa Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467181, "A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00467181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*